Equities

Leoclan Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
7681:TYO

Leoclan Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)951.00
  • Today's Change0.00 / 0.00%
  • Shares traded800.00
  • 1 Year change+13.62%
  • Beta0.0100
Data delayed at least 15 minutes, as of Feb 18 2026 01:46 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

LEOCLAN Co.,Ltd is a Japan-based company mainly engaged in the medical total solution business. The Company operates in three business segments. The Medical Total Solution segment is engaged in the contract sale of medical equipment and medical information system products based on consulting for medical institutions, prevention and examination facilities, nursing care and welfare facilities, as well as the related maintenance services business, the building interior work and medical equipment construction business. The Remote Image Diagnosis Service segment is engaged in the provision of remote diagnosis services through image data taken by magnetic resonance imaging (MRI) and computed tomography (CT) for medical institutions without a radiation diagnosis specialist. The Provide Lunch segment is engaged in the provision of ordinary and recuperation meal services for nursing and welfare facilities.

  • Revenue in JPY (TTM)28.69bn
  • Net income in JPY237.07m
  • Incorporated2001
  • Employees155.00
  • Location
    Leoclan Co Ltd2-4-26, SenriokaSETTSU-SHI 566-0001JapanJPN
  • Phone+81 663871554
  • Fax+81 663879895
  • Websitehttps://www.leoclan.co.jp
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
7681:TYO since
announced
Transaction
value
Fascia Holdings IncDeal completed19 Aug 202519 Aug 2025Deal completed-6.86%48.34m
Data delayed at least 15 minutes, as of Feb 18 2026 01:46 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Dentas Co Ltd891.68m3.89m1.22bn35.00----42.371.379.619.612,199.67-2.591.754.148.2022,863,590.001.01-3.313.25-6.0131.7330.050.578-2.320.6147-2.540.9278--6.1916.41165.10------
Platz Co Ltd8.33bn148.61m2.93bn149.0018.780.867310.110.351641.8541.852,389.99906.281.325.226.9655,907,800.002.353.423.344.7230.2132.541.783.041.61--0.441332.8931.866.67193.84-17.5946.84-14.76
Atect Corp3.28bn132.33m3.33bn122.0025.061.829.341.0129.9329.93742.77412.050.67833.546.2026,915,420.002.730.73124.291.0140.2545.424.031.310.619421.440.553299.430.80941.46116.440.8989-28.2927.23
Kowa Co Ltd6.42bn441.13m4.37bn218.008.211.126.350.681105.84105.841,540.98776.241.283.166.3429,460,510.009.0510.1713.9515.6944.0445.877.098.712.048.900.056713.09-0.55491.23-13.26--14.51-6.73
Leoclan Co Ltd28.69bn237.07m5.52bn155.0023.551.0112.420.192439.5839.584,841.68922.241.8734.116.11185,101,400.001.672.342.934.7813.1411.260.89321.201.4149.670.480934.118.51-0.465612.294.8012.954.98
Data Horizon Co Ltd5.18bn-2.30bn6.14bn367.00--20.34--1.19-181.31-181.31407.7923.740.746621.802.4414,102,500.00-33.20---54.27--36.77---44.47--1.29-3.050.9424--------------
Precision System Science Co Ltd5.03bn-35.13m6.64bn151.00--1.7135.911.32-1.28-1.28184.10140.030.89592.265.9233,309,860.00-0.6257-4.14-0.8672-5.5530.2630.20-0.6984-6.051.521.910.1787--17.91-1.5277.43---25.44--
Aso International Inc3.95bn473.61m7.01bn310.0015.062.3813.591.7747.4947.49396.47300.461.1916.337.9512,754,750.0014.20--16.71--44.89--11.98--4.7031.510.00--7.10--13.50------
Yamashita Health Care Holdings Inc63.77bn412.00m9.09bn613.0021.470.995514.200.1425165.78165.7825,574.613,576.032.4314.255.39104,027,700.001.562.244.396.5313.5013.100.6430.89750.945--0.0032.954.76-0.05346.216.0343.356.79
Koken Ltd11.86bn885.29m9.84bn321.0010.720.68717.560.8299179.77179.772,408.462,805.840.54762.482.30--4.093.905.214.9545.4045.897.477.411.6823.740.295719.1510.173.1522.611.11-11.116.96
Kainos Laboratories Inc5.46bn597.66m10.38bn157.0016.061.3514.861.90141.77141.771,294.101,688.390.61923.033.0734,748,430.006.787.128.129.3248.0951.5710.9611.493.45--0.071721.114.932.850.47879.976.9016.36
Create Medic Co Ltd13.62bn713.73m10.83bn1.00k13.750.57558.440.795681.5281.521,540.661,947.780.67761.814.29--3.553.014.073.5244.0244.005.244.514.8135.350.043959.804.514.69-15.121.591.663.99
JMS Co Ltd66.09bn-224.00m10.91bn5.47k--0.25894.550.165-9.15-9.152,695.911,703.210.76512.443.5412,084,290.00-0.36580.7427-0.53821.1022.7723.52-0.47810.88361.076.050.393671.626.833.56347.22-46.21-1.640.00
Data as of Feb 18 2026. Currency figures normalised to Leoclan Co Ltd's reporting currency: Japanese Yen JPY
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.